Abstract | BACKGROUND: METHODS: RESULTS: Five-year survival was significantly better in the prophylactic group compared with the emergency group. During the 5-year observation period, 20 of the 68 patients in the emergency group experienced rebleeding and 5 patients died as a result of rebleeding. These rates were significantly higher than those in the prophylactic group (1 of 9 patients with bleeding died among the 92 prophylactic sclerotherapy patients). Multivariate analysis showed that prophylactic therapy and Child's C hepatic function were significant factors for 5-year survival. CONCLUSIONS:
|
Authors | Tomofumi Ogusu, Ryuichi Iwakiri, Hiroyuki Sakata, Keiji Matsunaga, Ryo Shimoda, Kayoko Oda, Kenichirou Watanabe, Hibiki Ootani, Atsushi Kikkawa, Akifumi Ootani, Seiji Tsunada, Kazuma Fujimoto |
Journal | Journal of gastroenterology
(J Gastroenterol)
Vol. 38
Issue 4
Pg. 361-4
( 2003)
ISSN: 0944-1174 [Print] Japan |
PMID | 12743776
(Publication Type: Comparative Study, Evaluation Study, Journal Article)
|
Chemical References |
- Oleic Acids
- Sclerosing Solutions
- ethanolamine oleate
|
Topics |
- Adult
- Aged
- Emergency Treatment
- Esophageal and Gastric Varices
(etiology, mortality, therapy)
- Female
- Hemostasis, Endoscopic
- Humans
- Injections
- Liver Cirrhosis
(complications, mortality)
- Male
- Middle Aged
- Oleic Acids
(administration & dosage)
- Prognosis
- Sclerosing Solutions
(administration & dosage)
- Sclerotherapy
- Survival Rate
|